Tandem Diabetes Care, Inc. - Common Stock – Quartalsfinanzdaten (NASDAQ:TNDM)

Financials

Mittelzufluss aus laufender Geschäftstätigkeit 10.72 M-18.28 M-9.5 M8.26 M9.79 M11.05 M 19.61 M Mittelzufluss aus Investitionstätigkeit 5.01 M9.19 M58.13 M20.54 M-14.98 M-195.45 M -131.76 M Zahlungsströme aus der Finanzierungstätigkeit 2.3 M-4.69 M-39.71 M-1.57 M2.6 M274.16 M 235.48 M Freier Cashflow 10.72 M-18.28 M-9.5 M8.26 M9.79 M11.05 M 19.61 M

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.

TNDM

Financials

Tandem Diabetes Care, Inc. - Common Stock

Nachrichten

Silver Economy Investing: Why the Healthcare Giants Are in Focus

TNDM Stock Down Following Q1 Earnings & Revenue Beat, Gross Margin Up

Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?

Tandem Diabetes Care, Inc. (TNDM) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Tandem Diabetes Care (TNDM) Loses 26.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Benchmark stuft Tandem Diabetes mit ’Halten’ ein – Vertriebsumstellung birgt Risiken

Tandem Diabetes Care, Inc. (TNDM) Q1 2026 Earnings Call Transcript

Company News for May 8, 2026

Tandem Diabetes: Rekordumsatz und Rückkehr zur Profitabilität im ersten Quartal 2026

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

TD Cowen hebt Kursziel für Tandem Diabetes auf 28 US-Dollar an